Eli Lilly and Company

Lilly 30x30 is the company's goal to create new access to quality health care for 30 million people in resource-limited settings by the year 2030. To reach that goal, we have to find new solutions across our business and with our partners.

COLLABORATIONS

SHOWING 5 of 20 COLLABORATIONS

See All

Pat-INFORMED – The Gateway to Medicine Patent Information

Pat-INFORMED, a private-public partnership between the World Intellectual Property Organisation, the...

TransCelerate Biopharma

TransCelerate is a nonprofit organization with the mission to collaborate across the biopharmaceutical...

AbbVie, Astellas Pharma Inc, AstraZeneca, Boehringer Ingelheim, Bristol-Myers Squibb, Eli Lilly and Company, F. Hoffmann – La Roche Ltd., GlaxoSmithKline, Johnson & Johnson, Merck, MSD, Pfizer Inc, Sanofi, UCB

TB Drug Accelerator Program

Aiming to speed up the discovery and development of novel compounds against tuberculosis (TB)....

AbbVie, AstraZeneca, Bayer AG, Eisai, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson, MSD

Access Accelerated Initiative

Tackling the growing burden of non-communicable diseases in low and middle-income countries and supporting...

Access Accelerated, Almirall, Astellas Pharma Inc, Bayer AG, Bristol-Myers Squibb, Celgene, Chiesi Farmaceutici, Chugai Pharmaceutical, Daiichi Sankyo, Eisai, Eli Lilly and Company, F. Hoffmann – La Roche Ltd., International Federation of Pharmaceutical Manufacturers & Associations, Johnson & Johnson, Menarini Group, Merck, MSD, Novartis, Pfizer Inc, Sanofi, Servier, Shionogi & Co., Ltd., Sumitomo Dainippon, Takeda Pharmaceutical Company Limited, UCB

Global Alliance for TB Drug Development (TB Alliance)

The Global Alliance for TB Drug Development (TB Alliance) brings together industry, NGOs, governments,...

AstraZeneca, Bayer AG, Eli Lilly and Company, GlaxoSmithKline, Johnson & Johnson, Novartis

SHOWING 5 of 20 COLLABORATIONS

See All